SCHEMBL3156387

SCHEMBL3156387

CC(=O)NCCNc1cc(NCCNC(=O)Cc2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.48
ADORA1 P30542 3/20 0.48
CYP1A2 P05177 7/20 0.46
CYP3A4 P08684 7/20 0.46
CLK4 Q9HAZ1 6/20 0.46
ALDH1A1 P00352 5/20 0.46
HSD17B10 Q99714 3/20 0.46
ALOX15 P16050 2/20 0.46
MAPK1 P28482 1/20 0.46
ADORA3 P0DMS8 2/20 0.46
CYP2D6 P10635 4/20 0.45
TSHR P16473 3/20 0.45
CYP2C19 P33261 2/20 0.45
TP53 P04637 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
RECQL P46063 1/20 0.45
HBB P68871 1/20 0.45
USP2 O75604 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162245 0.95 ALDH1A1 (0.47) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3171179 0.93 KMT2A (0.50) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3170639 0.92 KMT2A (0.48) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3166463 0.92 CNR1 (0.47) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3163133 0.91 TP53 (0.49) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3169166 0.90 ALDH1A1 (0.49) ADORA2AADORA1CYP1A2CYP3A4ALDH1A1
SCHEMBL3166238 0.90 ALDH1A1 (0.54) ADORA2ACYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL3168745 0.90 ADORA2A (0.56) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3176019 0.89 CYP1A2 (0.57) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3172454 0.88 ADORA1 (0.54) ADORA2AADORA1CYP1A2CYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed